Schedule 13D ownership disclosure
VIRACTA THERAPEUTICS INC
Security class unavailable · CUSIP: 92765F108
Event date: 2022-06-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.0300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-23-000132
- Form type
- SC 13D
- Filer
- Schindel Yair Chaim
- CIK
- CIK 1823758
- Filed
- Jan 10, 2023
- Reporting period
- Jun 08, 2022
- Description
- Schedule 13D beneficial ownership